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ABSTRACT 
 
 Background 
The optimal administration of conscious sedation and patient monitoring during 
gastrointestinal endoscopy has not been well emphasized. Benzodiazepines are most 
commonly used, often with pethidine. Anesthetic agents are less frequently used 
because oversedation may induce respiratory depression, hypotension, and other 
cardiopulmonary complications. In this study we analysed the hemodynamic and 
respiratory effects of propofol on patients undergoing gastroscopy and colonoscopy.  
 
Methods  
In this prospective study, conducted over a period of three years, 1,104 patients 
referred for a same day GI endoscopy procedure were analyzed. All patients were 
given a propofol bolus (0.5-1.5 mg/kg). Arterial blood pressure (BP) was monitored at 
3 min intervals and heart rate and oxygen saturation (SpO2) were recorded 
continuously by pulse oximetry. Analyzed data acquisition was carried out before, 
during, and after the procedure. 
 
 
 6 
Results  
A statistically significant reduction in mean arterial pressure was demonstrated 
(p<0.001) when compared to pre-intervention values, but severe hypotension, defined 
as a systolic blood pressure below 60 mmHg, was noted in only 5 patients (0.5%). 
Oxygen saturation decreased from 96.5% to 94.4 % (p<0.001). A critical decrease in 
oxygen saturation (<90%) was documented in 27 patients (2.4%).  
 
Conclusion  
Our results showed that propofol provided good sedation with excellent pain control, a 
short recovery time and no significant hemodynamic side effects. All high risk 
patients (ASA III group) require monitoring and care of an anesthesiologist. 
 
Author keywords: endoscopy; conscious sedation; propofol; hemodynamic adverse 
effects 
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1. INTRODUCTION 
 
Gastrointestinal endoscopy remains to date an essential diagnostic and therapeutic 
tool. Patient comfort during the procedure is of paramount importance for successful 
completion of the examination (1,2). A significant subset of patients is unable to 
tolerate gastrointestinal endoscopic procedures without sedation (3,4). Midazolam and 
benzodiazepines are most commonly used, often in combination with pethidine, 
whereas anesthetic agents are less frequently used (5-8). Optimal administration of 
conscious sedation and patient monitoring during endoscopy has not been adequately 
emphasized so far (9). 
The optimal strategy of conscious sedation should be tailored to the individual patient, 
based on the experience of the gastroenterologist and anesthesiologist. Oversedation 
may induce respiratory depression and delayed recovery in elderly patients and in 
those with inherent cardiopulmonary compromise. Hypoxemia and hypotension 
represent the majority of complications observed, especially in upper intestinal 
endoscopy (11), and may occur more frequently during endoscopic procedures than 
during anesthesia. 
Gastrointestinal procedures require careful patient monitoring especially in the high-
risk patient population.  Patient vital signs have been monitored in less than 25.9% of 
cases, in the published literature (9).  
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The purpose of this study was to analyze the hemodynamic and respiratory effects of 
propofol on patients undergoing gastroscopy and colonoscopy and thus determine 
whether the monitoring and care of an anesthesiologist is required.   
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2. METHODS 
2.1. Patients 
We analyzed 1104 patients (639 women and 465 men) admitted for a same day 
colonoscopy (521 patients), gastroscopy (310 patients) or both procedures (273 
patients). The study was conducted prospectively over a three year period, from the 1st 
January 2001 to the 1st January 2004, at the Bates Clinic in Zagreb, Croatia. The 
median age of our patients was 53 years (range 17-88). Age, sex, body weight, blood 
pressure, heart rate, electrocardiogram, oxygen saturation, as well as patient history 
including current medication were recorded. We used the American Society of 
Anesthesiology classification system (ASA grades I-IV) to stratify patients by risk 
prior to the gastrointestinal procedure. Seven hundred and nine patients were in ASA 
group I (healthy patients), 361 in ASA II (patients with disease of one body system), 
and 35 in ASA III (patients with disease of more than one body system) (Table 1). 
After written informed consent had been obtained, an intravenous cannula was 
inserted. All patients were monitored throughout the procedure by the 
anesthesiologist.  
 
2.2. Procedure 
The patients were given an intravenous propofol (2,6–di–isopropylphenol, Diprivan, 
Astra Zeneca, USA) bolus (0.5-1.5 mg/kg). The required dose was calculated by the 
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anesthesiologist based on the patient‘s weight, age, physical condition, and estimated 
duration of procedure. Supplemental nasal oxygen was administered at 4 l/min during 
the procedure. Oxygen saturation and heart rate were monitored continuously by pulse 
oximetry and blood pressure was recorded at three minute intervals. These values 
were obtained before, during and after the endoscopic procedure (Table 2). Following 
the completion of the procedure, the patients were transferred to a recovery room and 
were closely observed for 30 minutes. The anesthesiologist recorded an overall pain 
score, complications and recovery time. 
 
2.3. Statistical Analysis 
Contingency tables were made for qualitative data and distribution parameters (mean, 
standard deviation, minimum and maximum) were calculated for all measured 
variables (systolic and diastolic blood pressure, heart rate, oxygen saturation and 
propofol per kg body weight). Paired t-test was used to test differences between pairs  
of values for all measured hemodynamic variables before, during and after the 
procedure. 
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3. RESULTS 
 
 A mean dose of 135 mg (60 – 480 mg/kg) of propofol was administered. After an 
initial dose of  0.5–1.5 mg/kg  (ASA I and II) or 0.25–0.5 mg/kg in patients ASA class 
III or over 70 years, the required dose of the anesthetic agent was estimated by the 
anesthesiologist based on the patient’s weight, age, physical condition and duration of 
the procedure. 
 We analyzed arterial blood pressure, oxygen saturation and heart rate (Table 2). 
Blood pressure and heart rate decreased during the procedure (p<0.0001) and 
increased after (p< 0.0001) an initial value. Our results showed that propofol in 
dosages of 0.5-1.5 mg/kg decreased the systolic blood pressure from 149.8 to 112.2 
mmHg, diastolic blood pressure from 80.6 to 68.4 mmHg and heart rate from 88.4 to 
81.3 beats/min. Hypotension, defined as a blood pressure bellow 60 mmHg, was 
recorded in 5 patients and they received a 500 ml normal saline bolus. Bradycardia, 
defined as a heart rate less than 50/min, was recorded in 7 patients (0.6%) and they 
received 0.5 mg of atropine. All medications were administered by the attending 
anesthesiologist. Oxygen saturation also decreased during the procedure from 96.5% 
to 94.4% (p<0.001). Oxygen saturation of less than 90% was documented in 27 
patients (2.4%). Seven of them were in ASA class III with cardiopulmonary disease, 
14 patients with hypertension and obesity and 6 patients were older than 80 years. All 
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hypoxemic episodes occurred in patients undergoing an upper GI examination. No 
episodes of apnea occurred and mechanical ventilation was not employed in any of 
our patients. The hypoxemia proved to be transient in all the patients. 
 The endoscopic procedures themselves caused no complications. Total colonoscopy 
was achieved in all but 6 patients who had subtotal stenosis. None of our patients 
reported any pain. Median recovery time was 7 minutes (range 5-15). Five patients 
had nausea but no intervention was needed. There were no serious respiratory or 
hemodynamic complications. 
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4. DISCUSSION 
  
Our choice of agent for the establishment of conscious sedation was propofol, a short 
acting anesthetic agent. In comparison with conventional sedation using midazolam or 
benzodiazepines, it provides a considerably more rapid onset of action and shorter 
recovery time (10,19,20). We believe it is a safe alternative for patients undergoing 
endoscopic procedures. In this study, none of the patients sedated with propofol 
reported any pain, and the mean recovery time was 7 minutes (5-15 min).    
The choice of sedative in GI procedures is largely operator dependent, but generally 
consists of benzodiazepines used either alone or in combination with an opiate (5-8). 
Such combination may increase the risk of oxygen desaturation and cardiorespiratory 
complications (2,4,9). Trojan et al. (14) demonstrated that the residual effects of 
midazolam on psychomotor function could be documented for at least 1 h after its 
administration. Paradoxical reactions, including hyperactive or aggressive behavior 
have been reported (4). The anesthetic agents, such as droperidol, propofol and 
general anesthesia are reserved for patients who remain uncooperative on standard 
regimens or who are perceived to be at high risk for agitation unless a deeper level of 
sedation is achieved (15-17). General anesthesia is used most commonly in children. 
Sedation with midazolam, benzodiazepines, analgetics and propofol was administered 
in many studies by the nurse and the endoscopist (10,14,18-20). In certain settings, 
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assistance from an anesthesiologist may be required. Some authors suggest that GI 
procedures without sedation are satisfactory (4,6,9,18), but in our previous study (21) 
we showed that 50% of patients without sedation reported the procedure as painful. 
Our results showed that propofol in dosages of 0.5-1.5 mg/kg decreased the systolic 
and diastolic blood pressure and heart rate during the procedure and increased after an 
initial value. Hypotension and respiratory depression represent the majority of the 
complications observed (10,11,22-24).  In our study only 5 patients had hypotension 
and 7 patients developed bradycardia. Most of these patients were obese with 
cardiopulmonary disease and a compromised general physical condition (ASA class 
III). Electrocardiographic changes during GI procedures, especially gastroscopy, are 
common and reported in patients with known heart disease as well as otherwise 
healthy patients (24). Approximately a half of all the complications observed during 
gastroscopy are of cardiopulmonary origin (12). In our study 3 patients developed 
ventricular premature beats whereas 5 patients went into a supraventricular 
tachycardia with a ventricular rate exceeding 140 beats/min. These rhythm 
abnormalities were of short duration and caused no hemodynamic compromise. 
Monitoring of cardiopulmonary function during endoscopic procedures is of outmost 
importance and we believe that a significant reduction in morbidity and mortality can 
thus be achieved. The most widely used definition of hypoxemia is an oxygen 
saturation of below 90% and monitoring of oxygen saturation is more sensitive than a 
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clinical detection of cyanosis. Respiratory complications with oxygen desaturation 
were recorded in 2.4% patients in our study. We prevented hypoxemia with 
administration of supplementary of 4 l/min oxygen. Numerous studies have 
documented the occurrence of hypoxemia during endoscopy (6,23-25). They reported 
cardiopulmonary complications with oxygen desaturations in 40-60% of patients with 
sedation, and some studies have reported desaturation in 40% of unsedated patients 
(23). Obesity, pulmonary disease, age and mechanical airway obstruction worsened 
hypoxemia. Their recommendation consisted of pulse oximetry monitoring. 
Intermittent oxygen desaturation is also common during sleep in normal subject (25). 
Others showed that hypoxemia can be prevented by providing supplemental oxygen 
(5,23). Gastrointestinal societies in the United States and United Kingdom issued 
guidelines for monitoring and oxygen administration (23,24). All patients in ASA III 
group require monitoring and care of an anesthesiologist. Our results showed that 
propofol provided good sedation and short recovery time. The procedure is rendered 
painless and no significant respiratory or hemodynamic deteriorations have been 
observed. Monitoring of blood pressure, heart rate, ECG and oxygen saturation is 
necessary, as is supplemental administration of oxygen. While some authors 
recommended that sedation with propofol by nonanesthetists or nurses (10) are 
acceptable, we believe that conscious sedation administration and monitoring by an 
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anesthesiologist with an inherent high index of suspicion for potential complications 
might be a safer strategy. 
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Table 1. ASA physical status classification 
 
  
Procedure Total 
ASA 
group 
Colonoscopy Gastroscopy Both 
procedures 
I 335 209 165 709 
II 172 90 98 360 
III 14 11 10 35 
Total 521 310 273 1104 
*ASA-American Society of Anesthesiology
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Table 2. Data on basic laboratory parameters measured before, during and after GI 
procedures  
 Findings in patients (mean +/- SD) Number of monitored patients 
Parameter Before 
procedure 
During 
procedure 
After 
procedure 
 
 Before 
procedure 
During 
procedur
e 
After 
procedu
re 
 
SBP 
(mmHg) 
140.8+/-26.0 
 
112.2+/-25.3 
114.6+/-23.7 1,096 880 1,037 
DBP 
(mmHg) 
80.6+/-13.3 68.4+/-14.1   70.1+/-12.9 
 
1,096 880 1,035 
HR 
(beats/min) 
88.4+/-19.1 
 
81.3+/-14.3 
 
  80.1+/-13.9 
 
1,012 888 1,049 
SpO2 (%) 96.5+/-2.9 94.4+/-4.1 95.3+/-3.4 997 885 1,046 
*Abbreviations: SBP-systolic blood pressure, DBP-diastolic blood pressure, HR-heart rate, SpO2-oxygen saturation, SD–standard deviation
 
 
 
 
 
 
 
